Levine Leichtman partner Mike Weinberg talks investing in pharma services; KKR closes 13th flagship on $19bn

KKR racks up $19 billion for newest fund.

25 April 2022•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.